First Time Loading...

MEI Pharma Inc
NASDAQ:MEIP

Watchlist Manager
MEI Pharma Inc Logo
MEI Pharma Inc
NASDAQ:MEIP
Watchlist
Price: 3.06 USD Market Closed
Updated: May 3, 2024
Section:
 

Wall Street
Price Targets

MEIP Price Targets Summary
MEI Pharma Inc

Wall Street analysts forecast MEIP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MEIP is 23.46 USD with a low forecast of 7.07 USD and a high forecast of 44.1 USD.

MEIP Lowest Forecast
Wall Street Target
7.07 USD
131% Upside
MEIP Average Forecast
Wall Street Target
23.46 USD
667% Upside
MEIP Highest Forecast
Wall Street Target
44.1 USD
1 341% Upside
Lowest
Price Target
7.07 USD
131% Upside
Average
Price Target
23.46 USD
667% Upside
Highest
Price Target
44.1 USD
1 341% Upside
MEI Pharma Inc Competitors:
Price Targets
OPK
OPKO Health Inc
233% Upside
VITR
Vitrolife AB
41% Upside
N
688105
Nanjing Vazyme Biotech Co Ltd
56% Upside
B
600161
Beijing Tiantan Biological Products Corp Ltd
16% Upside
OPK
OPKO Health Inc
233% Upside
VITR
Vitrolife AB
41% Upside
N
688105
Nanjing Vazyme Biotech Co Ltd
56% Upside
B
600161
Beijing Tiantan Biological Products Corp Ltd
16% Upside
3164
GenMont Biotech Inc
340% Upside
AGIO
Agios Pharmaceuticals Inc
26% Upside
A
ALRN
Aileron Therapeutics Inc
407% Upside
LGND
Ligand Pharmaceuticals Inc
65% Upside

Revenue
Forecast

Revenue Estimate
MEI Pharma Inc

The compound annual growth rate of MEI Pharma Inc's revenue for the next 3 years is -19%.

N/A
Past Growth
-19%
Estimated Growth
Estimates Accuracy
-44%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
MEI Pharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
MEI Pharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
MEIP intrinsic value, competitors valuation, and company profile.
DCF Valuation
MEIP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MEIP stock valuation using valuation multiples.
Wall Street Estimates
MEIP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MEIP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MEIP's stock price target?
Price Target
23.46 USD

According to Wall Street analysts, the average 1-year price target for MEIP is 23.46 USD with a low forecast of 7.07 USD and a high forecast of 44.1 USD.

What is MEI Pharma Inc's Revenue forecast?
Projected CAGR
-19%

The compound annual growth rate of MEI Pharma Inc's revenue for the next 3 years is -19%.

ALPHA SPREAD
Join more than 133,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.